Growing community of inventors

Riga, Latvia

Reinis Vilskersts

Average Co-Inventor Count = 8.57

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Reinis VilskerstsEinars Loza (3 patents)Reinis VilskerstsIvars Kalvins (3 patents)Reinis VilskerstsMaija Dambrova (3 patents)Reinis VilskerstsSolveiga Grinberga (3 patents)Reinis VilskerstsOsvalds Pugovics (3 patents)Reinis VilskerstsEdgars Liepins (3 patents)Reinis VilskerstsJanis Kuka (3 patents)Reinis VilskerstsIlmars Stonans (1 patent)Reinis VilskerstsAnatolijs Birmans (2 patents)Reinis VilskerstsDaina Lola (1 patent)Reinis VilskerstsDaina Gustina (1 patent)Reinis VilskerstsMarina Makrecka (1 patent)Reinis VilskerstsViktors Andrianovs (1 patent)Reinis VilskerstsEinars Loza (1 patent)Reinis VilskerstsIvars Kalvins (0 patent)Reinis VilskerstsReinis Vilskersts (3 patents)Einars LozaEinars Loza (18 patents)Ivars KalvinsIvars Kalvins (15 patents)Maija DambrovaMaija Dambrova (8 patents)Solveiga GrinbergaSolveiga Grinberga (4 patents)Osvalds PugovicsOsvalds Pugovics (4 patents)Edgars LiepinsEdgars Liepins (4 patents)Janis KukaJanis Kuka (4 patents)Ilmars StonansIlmars Stonans (4 patents)Anatolijs BirmansAnatolijs Birmans (2 patents)Daina LolaDaina Lola (2 patents)Daina GustinaDaina Gustina (1 patent)Marina MakreckaMarina Makrecka (1 patent)Viktors AndrianovsViktors Andrianovs (1 patent)Einars LozaEinars Loza (3 patents)Ivars KalvinsIvars Kalvins (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Jsc Grindeks (3 from 9 patents)

2. Grindeks, a Joint Stock Company (1 patent)


3 patents:

1. 10351534 - Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease

2. 9573882 - Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease

3. 9278907 - Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…